Molecular cloning of a human homologue of Drosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificity

William S. Saunders(Johns Hopkins University), Calvin Chue(Johns Hopkins University), Mark Goebl(Indiana University School of Medicine), Carolyn A. Craig(Washington University in St. Louis), Robert Clark(Washington University in St. Louis), James Powers(Saint Louis University), Joel C. Eissenberg(Saint Louis University), Sarah C. R. Elgin(Washington University in St. Louis), Naomi F. Rothfield(UConn Health), William C. Earnshaw(Johns Hopkins University)
Journal of Cell Science
February 1, 1993
Cited by 165

Abstract

We have identified a novel autoantibody specificity in scleroderma that we term anti-chromo. These antibodies recognize several chromosomal antigens with apparent molecular mass of between 23 and 25 kDa, as determined by immunoblots. Anti-chromo autoantibodies occur in 10-15% of sera from patients with anti-centromere antibodies (ACA). We used anti-chromo antibodies to screen a human expression library and obtained cDNA clones encoding a 25 kDa chromosomal autoantigen. DNA sequence analysis reveals this protein to be a human homologue of HP1, a heterochromatin protein of Drosophila melanogaster. We designate our cloned protein HP1Hs alpha. Epitope mapping experiments using both human and Drosophila HP1 reveal that anti-chromo antibodies target a region at the amino terminus of the protein. This region contains a conserved motif, the chromo domain (or HP1/Pc box), first recognized by comparison of Drosophila HP1 with the Polycomb gene product. Both proteins are thought to play a role in creating chromatin structures in which gene expression is suppressed. Anti-chromo thus defines a novel type of autoantibody that recognizes a conserved structural motif found on a number of chromosomal proteins.


Related Papers

No related papers found

Powered by citation graph analysis